Date: 22 Jun 2023 to 24 Jun 2023

2023 Pediatric Neuro-Oncology Research Conference

Venue: Capital Hilton, Washington DC


Event Notes:

Building on the success of our previous pediatric meetings, this biennial conference encourages the sharing of ideas and results, new collaborations and offers attendees a state-of-the-art update in the field of pediatric brain tumor research. The scientific program will offer outstanding keynotes, panel discussions and abstract presentations on a range of timely themes shaping the future of pediatric neuro-oncology. Topics the conference will include developmental origins of pediatric brain tumors, novel approaches in cancer neuroscience, artificial intelligence, and machine learning, focused ultrasound/drug delivery, diversity & inclusion, novel immunotherapeutic findings, clinical trial reports, and single cell approaches to decipher molecular landscapes. Conference participants will also have opportunities to present their work — and to learn about advances made by others — through short oral presentations and scientific posters selected by the abstract review committee.


Who Should Attend

Pediatric neuro-oncologists, medical oncologists, neurosurgeons, radiation oncologists, radiologists, physician/scientists, clinical and laboratory trainees, and allied health professionals.

Learning Objectives

  • Cite the developmental origins of pediatric brain tumors.
  • Summarize the interactions between normal cells of the nervous system and cancer cells.
  • Explain how artificial intelligence and machine learning approaches can leverage big genomic data sets in cancer biology towards improved treatment options for pediatric patients with CNS tumors.
  • Identify new therapeutic delivery options that effectively treat pediatric patients with brain tumors protected by the blood brain barrier.
  • Summarize recent advances in the experimental and clinical approach to the treatment of pediatric patients with brain tumors
  • Identify recent developments and advances in translational and correlative biology and implications for discovery of novel treatments for pediatric patients with brain tumors.


Sunrise Sessions

  • Diversity, Equity, and Inclusion – Co-Chairs: Cassie Kline and Jessica Tsai
  • Focused Ultrasound – Co-Chairs: Javad Nazarian and Ying Meng
  • Immunology/CAR T Cells – Co-Chairs: Catherine Flores and Siddhartha Mitra
  • New Approaches to Drug Delivery – Co-Chairs: Joelle Straehla and Praveen Raju
  • Cancer Neuroscience – Co-Chairs: David Gutmann and Michelle Monje
  • Models of Pediatric Brain Tumors – Chair: Marcel Kool


What To Expect

  • Lectures, Q&A sessions, posters and poster discussions
  • Live activities to earn AMA PRA Category  1 Credit™ and CME Certificate
  • Opportunities to engage with industry and nonprofit partners
  • Accepted abstracts to be published in SNO’s flagship journal Neuro-Oncology
  • Additional Day of Educational Content
  • Expanded Education for Early Career Professionals
  • New Welcome Reception
  • More Networking
  • Special Nonprofit Showcase


Conference Scientific Co-chairs

Mariella Filbin – Dana-Farber Cancer Institute and Boston Children’s Hospital
Eugene Hwang – Children’s National Hospital
Lindsay Kilburn – Children’s National Hospital